These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35036042)

  • 1. Impact of Warhead Modulations on the Covalent Inhibition of SARS-CoV-2 M
    Martí S; Arafet K; Lodola A; Mulholland AJ; Świderek K; Moliner V
    ACS Catal; 2022 Jan; 12(1):698-708. PubMed ID: 35036042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition of SARS-CoV-2 M
    Arafet K; Serrano-Aparicio N; Lodola A; Mulholland AJ; González FV; Świderek K; Moliner V
    Chem Sci; 2020 Nov; 12(4):1433-1444. PubMed ID: 34163906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    Angew Chem Int Ed Engl; 2021 Dec; 60(49):25933-25941. PubMed ID: 34581471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors.
    Kovalevsky A; Aniana A; Coates L; Bonnesen PV; Nashed NT; Louis JM
    J Biol Chem; 2023 Jul; 299(7):104886. PubMed ID: 37271339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    Chem Sci; 2021 Jan; 12(10):3489-3496. PubMed ID: 34163622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.
    Banerjee S
    Biophys Chem; 2021 Feb; 269():106510. PubMed ID: 33285430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes.
    Zhu Y; Meng J; Feng B; Zhao Y; Zang Y; Lu L; Su M; Yang Q; Zhang Q; Feng L; Zhao J; Shao M; Ma Y; Yang X; Yang H; Li J; Jiang X; Rao Z
    Structure; 2024 Jun; ():. PubMed ID: 38925121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease.
    Khatua K; Alugubelli YR; Yang KS; Vulupala VR; Blankenship LR; Coleman DD; Atla S; Chaki SP; Geng ZZ; Ma XR; Xiao J; Chen PC; Cho CD; Vatansever EC; Ma Y; Yu G; Neuman BW; Xu S; Liu WR
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale Simulations of the Covalent Inhibition of the SARS-CoV-2 Main Protease: Four Compounds and Three Reaction Mechanisms.
    Grigorenko BL; Polyakov IV; Khrenova MG; Giudetti G; Faraji S; Krylov AI; Nemukhin AV
    J Am Chem Soc; 2023 Jun; 145(24):13204-13214. PubMed ID: 37294056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the binding energetics of reversible covalent inhibitors of the SARS-CoV-2 main protease: an
    Awoonor-Williams E
    Phys Chem Chem Phys; 2022 Oct; 24(38):23391-23401. PubMed ID: 36128834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease.
    Hognon C; Marazzi M; García-Iriepa C
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete Dynamics of Warhead Modulation on Covalent Inhibition of Oxyr: A QM/MM Study.
    Zaman N; Azam SS
    J Phys Chem B; 2023 Jul; 127(27):5993-6005. PubMed ID: 37377002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.
    Vázquez-Mendoza LH; Mendoza-Figueroa HL; García-Vázquez JB; Correa-Basurto J; García-Machorro J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease:
    Nutho B; Wilasluck P; Deetanya P; Wangkanont K; Arsakhant P; Saeeng R; Rungrotmongkol T
    Comput Struct Biotechnol J; 2022; 20():2784-2797. PubMed ID: 35677603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    ACS Catal; 2021 Apr; 11(7):4157-4168. PubMed ID: 34192090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the binding mechanism of inhibitors of the SARS-CoV-2 main protease through multiple replica accelerated molecular dynamics simulations and free energy landscapes.
    Li M; Liu X; Zhang S; Liang S; Zhang Q; Chen J
    Phys Chem Chem Phys; 2022 Sep; 24(36):22129-22143. PubMed ID: 36082845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast and Effective Prediction of the Absolute Binding Free Energies of Covalent Inhibitors of SARS-CoV-2 Main Protease and 20S Proteasome.
    Zhou J; Saha A; Huang Z; Warshel A
    J Am Chem Soc; 2022 May; 144(17):7568-7572. PubMed ID: 35436404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).
    Taranto AG; Carvalho P; Avery MA
    J Mol Graph Model; 2008 Oct; 27(3):275-85. PubMed ID: 18567519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones.
    Mihalovits LM; Kollár L; Bajusz D; Knez D; Bozovičar K; Imre T; Ferenczy GG; Gobec S; Keserű GM
    Chemphyschem; 2024 Jan; 25(1):e202300596. PubMed ID: 37888491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.